Cargando…
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study
BACKGROUND: There is an urgent need for biomarkers to better stratify patients with idiopathic pulmonary fibrosis by risk for lung transplantation allocation who have the same clinical presentation. We aimed to investigate whether a specific immune cell type from patients with idiopathic pulmonary f...
Autores principales: | Scott, Madeleine K D, Quinn, Katie, Li, Qin, Carroll, Robert, Warsinske, Hayley, Vallania, Francesco, Chen, Shirley, Carns, Mary A, Aren, Kathleen, Sun, Jiehuan, Koloms, Kimberly, Lee, Jungwha, Baral, Jessika, Kropski, Jonathan, Zhao, Hongyu, Herzog, Erica, Martinez, Fernando J, Moore, Bethany B, Hinchcliff, Monique, Denny, Joshua, Kaminski, Naftali, Herazo-Maya, Jose D, Shah, Nigam H, Khatri, Purvesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529612/ https://www.ncbi.nlm.nih.gov/pubmed/30935881 http://dx.doi.org/10.1016/S2213-2600(18)30508-3 |
Ejemplares similares
-
Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures
por: Warsinske, Hayley, et al.
Publicado: (2019) -
High-throughput quantitative histology in systemic sclerosis skin disease using computer vision
por: Correia, Chase, et al.
Publicado: (2020) -
Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?
por: Lakota, Katja, et al.
Publicado: (2012) -
Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic
Sclerosis
por: Lakota, Katja, et al.
Publicado: (2015) -
KLRD1-expressing natural killer cells predict influenza susceptibility
por: Bongen, Erika, et al.
Publicado: (2018)